Proteomic analysis of γ-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure

Myung Jeom Ryu, Daesoo Kim, Un Beom Kang, Joon Kim, Hee Sup Shin, Cheolju Lee, Myeong Hee Yu

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Absence seizure has been of interest because the symptom is related to sensory processing. However, the mechanism that causes the disease is not understood yet. To better understand the molecular mechanism related to the disease progress at protein level, we performed proteomic studies using the thalamus of mice for which absence seizure was induced by γ-butyrolactone (GBL). Differential proteome expression between GBL-treated mice and control mice was examined by fluorescence 2D difference gel electrophoresis (DIGE) at three different time points (5, 10, and 30 min) after GBL-administration. We identified 16 proteins differentially expressed by >1.4-fold at any of the three time points. All proteins besides the serine protease inhibitor EIA were down-regulated in absence seizure-induced mice. The down-regulated proteins can be classified into five groups by their biological functions: cytoskeleton rearrangement, neuroprotection, neurotransmitter secretion, calcium binding, and metabolism. The maximum level of change was reached by 10 min after GBL-treatment, with the expression level returning back to the original at 30 min when mice were awakened from absence seizure thereby demonstrating the proteomic response is reversible. Our results suggest that absence seizures are associated with restricted functional sets of proteins, whose down-regulation may interfere with general function of neuronal cells.

Original languageEnglish
Pages (from-to)646-656
Number of pages11
JournalJournal of Neurochemistry
Volume102
Issue number3
DOIs
Publication statusPublished - 2007 Aug 1

Fingerprint

Absence Epilepsy
Thalamus
Proteomics
Proteins
Serine Proteinase Inhibitors
Electrophoresis, Gel, Two-Dimensional
Proteome
Electrophoresis
Cytoskeleton
Metabolism
Neurotransmitter Agents
Down-Regulation
Fluorescence
Gels
Calcium
Processing

Keywords

  • γ-butyrolactone
  • Absence seizure
  • Fluorescence 2D difference gel electrophoresis
  • Proteome
  • Sensory processing
  • Thalamus

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Proteomic analysis of γ-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure. / Ryu, Myung Jeom; Kim, Daesoo; Kang, Un Beom; Kim, Joon; Shin, Hee Sup; Lee, Cheolju; Yu, Myeong Hee.

In: Journal of Neurochemistry, Vol. 102, No. 3, 01.08.2007, p. 646-656.

Research output: Contribution to journalArticle

Ryu, Myung Jeom ; Kim, Daesoo ; Kang, Un Beom ; Kim, Joon ; Shin, Hee Sup ; Lee, Cheolju ; Yu, Myeong Hee. / Proteomic analysis of γ-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure. In: Journal of Neurochemistry. 2007 ; Vol. 102, No. 3. pp. 646-656.
@article{3f12d0c364a24fba9a405c1ce671a266,
title = "Proteomic analysis of γ-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure",
abstract = "Absence seizure has been of interest because the symptom is related to sensory processing. However, the mechanism that causes the disease is not understood yet. To better understand the molecular mechanism related to the disease progress at protein level, we performed proteomic studies using the thalamus of mice for which absence seizure was induced by γ-butyrolactone (GBL). Differential proteome expression between GBL-treated mice and control mice was examined by fluorescence 2D difference gel electrophoresis (DIGE) at three different time points (5, 10, and 30 min) after GBL-administration. We identified 16 proteins differentially expressed by >1.4-fold at any of the three time points. All proteins besides the serine protease inhibitor EIA were down-regulated in absence seizure-induced mice. The down-regulated proteins can be classified into five groups by their biological functions: cytoskeleton rearrangement, neuroprotection, neurotransmitter secretion, calcium binding, and metabolism. The maximum level of change was reached by 10 min after GBL-treatment, with the expression level returning back to the original at 30 min when mice were awakened from absence seizure thereby demonstrating the proteomic response is reversible. Our results suggest that absence seizures are associated with restricted functional sets of proteins, whose down-regulation may interfere with general function of neuronal cells.",
keywords = "γ-butyrolactone, Absence seizure, Fluorescence 2D difference gel electrophoresis, Proteome, Sensory processing, Thalamus",
author = "Ryu, {Myung Jeom} and Daesoo Kim and Kang, {Un Beom} and Joon Kim and Shin, {Hee Sup} and Cheolju Lee and Yu, {Myeong Hee}",
year = "2007",
month = "8",
day = "1",
doi = "10.1111/j.1471-4159.2007.04504.x",
language = "English",
volume = "102",
pages = "646--656",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Proteomic analysis of γ-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure

AU - Ryu, Myung Jeom

AU - Kim, Daesoo

AU - Kang, Un Beom

AU - Kim, Joon

AU - Shin, Hee Sup

AU - Lee, Cheolju

AU - Yu, Myeong Hee

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Absence seizure has been of interest because the symptom is related to sensory processing. However, the mechanism that causes the disease is not understood yet. To better understand the molecular mechanism related to the disease progress at protein level, we performed proteomic studies using the thalamus of mice for which absence seizure was induced by γ-butyrolactone (GBL). Differential proteome expression between GBL-treated mice and control mice was examined by fluorescence 2D difference gel electrophoresis (DIGE) at three different time points (5, 10, and 30 min) after GBL-administration. We identified 16 proteins differentially expressed by >1.4-fold at any of the three time points. All proteins besides the serine protease inhibitor EIA were down-regulated in absence seizure-induced mice. The down-regulated proteins can be classified into five groups by their biological functions: cytoskeleton rearrangement, neuroprotection, neurotransmitter secretion, calcium binding, and metabolism. The maximum level of change was reached by 10 min after GBL-treatment, with the expression level returning back to the original at 30 min when mice were awakened from absence seizure thereby demonstrating the proteomic response is reversible. Our results suggest that absence seizures are associated with restricted functional sets of proteins, whose down-regulation may interfere with general function of neuronal cells.

AB - Absence seizure has been of interest because the symptom is related to sensory processing. However, the mechanism that causes the disease is not understood yet. To better understand the molecular mechanism related to the disease progress at protein level, we performed proteomic studies using the thalamus of mice for which absence seizure was induced by γ-butyrolactone (GBL). Differential proteome expression between GBL-treated mice and control mice was examined by fluorescence 2D difference gel electrophoresis (DIGE) at three different time points (5, 10, and 30 min) after GBL-administration. We identified 16 proteins differentially expressed by >1.4-fold at any of the three time points. All proteins besides the serine protease inhibitor EIA were down-regulated in absence seizure-induced mice. The down-regulated proteins can be classified into five groups by their biological functions: cytoskeleton rearrangement, neuroprotection, neurotransmitter secretion, calcium binding, and metabolism. The maximum level of change was reached by 10 min after GBL-treatment, with the expression level returning back to the original at 30 min when mice were awakened from absence seizure thereby demonstrating the proteomic response is reversible. Our results suggest that absence seizures are associated with restricted functional sets of proteins, whose down-regulation may interfere with general function of neuronal cells.

KW - γ-butyrolactone

KW - Absence seizure

KW - Fluorescence 2D difference gel electrophoresis

KW - Proteome

KW - Sensory processing

KW - Thalamus

UR - http://www.scopus.com/inward/record.url?scp=34447318851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447318851&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2007.04504.x

DO - 10.1111/j.1471-4159.2007.04504.x

M3 - Article

C2 - 17419809

AN - SCOPUS:34447318851

VL - 102

SP - 646

EP - 656

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -